NKF 2012 Spring Meeting

IV Iron Drugs Not Equal in Hemoglobin Response

NATIONAL HARBOR, Md.—In a recently completed clinical trial, treatment with ferumoxytol resulted in a greater hemoglobin (Hb) response than iron sucrose in hemodialysis (HD) patients with anemia and non-dialysis patients with severe anemia, researchers reported at the National Kidney Foundation 2012 Spring Clinical Meetings.

Next post in NKF 2012 Anemia